First of Several Post-hoc Analyses Planned Using HOPE Study Clinical Data Findings Presented in Poster Session at 13 th Annual Academy for Sickle Cell and Thalassemia Conference SOUTH SAN FRANCISCO, ...
One of the most vital treatments for sickle cell patients is regular blood transfusions; sometimes, it's needed multiple ...
Dr. Ayodele Ogunkeyede, a plastic, reconstructive and aesthetic surgeon with Hafar Al-batin Central Hospital, Hafar Albatin, Eastern Region, Saudi Arabia, has developed novel compression therapy for ...
Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...
A specialist from Oman, located at the crossroads of Africa and Asia, explains that his nation serves as a microcosm when it ...
Pain is a constant, complex companion that clinicians often struggle to understand and measure for people living with sickle ...
For the first time, U.S. regulators have cleared a treatment using CRISPR, the gene-editing technology, for patients. The product is Casgevy, a treatment for sickle cell disease and beta thalassemia, ...
Sickle-cell disease is the first illness to be beaten by CRISPR, but the new treatment comes with an expected price tag of $2 to $3 million. CRISPR Therapeutics, Editas Medicine, Precision BioSciences ...
Vinn Victory in tears at her Tairi Mbili home on the outskirts of Eldoret town in Uasin Gishu County. [Peter Ochieng, Standard] When Vinn Victory was diagnosed with sickle cell disease in 2016, she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback